{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:54:31Z","timestamp":1790999671101,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02296-z","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:34:39Z","timestamp":1787373279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased glioblastoma risk in patients with myeloproliferative neoplasms and myelodysplastic syndromes"],"prefix":"10.1007","volume":"26","author":[{"given":"Huaiyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"9","key":"2296_CR1","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1002\/cam4.2107","volume":"8","author":"B Mora","year":"2019","unstructured":"Mora B, Rumi E, Guglielmelli P, Barraco D, Maffioli M, Rambaldi A, et al. Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: a study on 2233 patients. Cancer Med. 2019;8(9):4089\u201392.","journal-title":"Cancer Med"},{"issue":"2","key":"2296_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/bjh.17192","volume":"193","author":"N Polverelli","year":"2021","unstructured":"Polverelli N, Elli EM, Abruzzese E, Palumbo GA, Benevolo G, Tiribelli M, et al. Second primary malignancy in myelofibrosis patients treated with ruxolitinib. Br J Haematol. 2021;193(2):356\u201368.","journal-title":"Br J Haematol"},{"issue":"4","key":"2296_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1474-4422(18)30468-X","volume":"18","author":"Global","year":"2019","unstructured":"Global. regional, and national burden of brain and other CNS cancer, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(4):376\u201393.","journal-title":"Lancet Neurol"},{"issue":"13","key":"2296_CR4","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","volume":"122","author":"T Barbui","year":"2013","unstructured":"Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood. 2013;122(13):2176\u201384.","journal-title":"Blood"},{"key":"2296_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100711","volume":"42","author":"S Koschmieder","year":"2020","unstructured":"Koschmieder S, Chatain N. Role of inflammation in the biology of myeloproliferative neoplasms. Blood Rev. 2020;42:100711.","journal-title":"Blood Rev"},{"key":"2296_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/mi\/9967975","volume":"2025","author":"M Chen","year":"2025","unstructured":"Chen M, Zheng C, Zhang Y, He J, Shi Z. Chronic inflammation in primary myelofibrosis: in-depth insights into pathogenesis and promising anti-inflammatory therapeutic strategies. Mediators Inflamm. 2025;2025:9967975.","journal-title":"Mediators Inflamm"},{"key":"2296_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1\u201312.","journal-title":"Brain Behav Immun"},{"key":"2296_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1755073","volume":"17","author":"C Lamorlette","year":"2026","unstructured":"Lamorlette C, Boura C, Pinel S, Bensoussan D, Dotti G, Alanio C, et al. The dynamic myeloid-enriched microenvironment of glioblastoma: a major challenge to immunotherapy efficacy. Front Immunol. 2026;17:1755073.","journal-title":"Front Immunol"},{"issue":"10","key":"2296_CR9","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41375-018-0027-y","volume":"32","author":"AR Landtblom","year":"2018","unstructured":"Landtblom AR, Bower H, Andersson TM, Dickman PW, Samuelsson J, Bj\u00f6rkholm M, et al. Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia. 2018;32(10):2203\u201310.","journal-title":"Leukemia"},{"issue":"5","key":"2296_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ng.3823","volume":"49","author":"BS Melin","year":"2017","unstructured":"Melin BS, Barnholtz-Sloan JS, Wrensch MR, Johansen C, Il\u2019yasova D, Kinnersley B, et al. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet. 2017;49(5):789\u201394.","journal-title":"Nat Genet"},{"key":"2296_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biology9020031","author":"VVV Hira","year":"2020","unstructured":"Hira VVV, Van Noorden CJF, Molenaar RJ. CXCR4 antagonists as stem cell mobilizers and therapy sensitizers for acute myeloid leukemia and glioblastoma? Biology (Basel). 2020. . https:\/\/doi.org\/10.3390\/biology9020031","journal-title":"Biology (Basel)"},{"issue":"1","key":"2296_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12951-023-02033-8","volume":"21","author":"LX Ling","year":"2023","unstructured":"Ling LX, Ouyang Y, Hu Y. Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023. J Nanobiotechnol. 2023;21(1):248.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"2296_CR13","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1097\/JS9.0000000000002248","volume":"111","author":"H Li","year":"2025","unstructured":"Li H, Li Z, Fu Q, Fu S, Xiang T. Exploring the landscape of exosomes in heart failure: a bibliometric analysis. Int J Surg. 2025;111(5):3356\u201372.","journal-title":"Int J Surg"},{"issue":"10440","key":"2296_CR14","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Global incidence","year":"2024","unstructured":"Global incidence. prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"1","key":"2296_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1162\/qss_a_00018","volume":"1","author":"C Birkle","year":"2020","unstructured":"Birkle C, Pendlebury DA, Schnell J, Adams J. Web of Science as a data source for research on scientific and scholarly activity. Quant Sci Stud. 2020;1(1):363\u201376.","journal-title":"Quant Sci Stud"},{"issue":"5","key":"2296_CR16","doi-asserted-by":"publisher","first-page":"e808","DOI":"10.1016\/S2214-109X(25)00013-0","volume":"13","author":"X An","year":"2025","unstructured":"An X, Liu Z, Zhang L, Zhao J, Gu Q, Han W, et al. Co-occurrence patterns and related risk factors of ischaemic heart disease and ischaemic stroke across 203 countries and territories: a spatial correspondence and systematic analysis. Lancet Glob Health. 2025;13(5):e808\u201319.","journal-title":"Lancet Glob Health"},{"issue":"1\u20132","key":"2296_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/biomet\/37.1-2.17","volume":"37","author":"PA Moran","year":"1950","unstructured":"Moran PA. Notes on continuous stochastic phenomena. Biometrika. 1950;37(1\u20132):17\u201323.","journal-title":"Biometrika"},{"issue":"2","key":"2296_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1538-4632.1995.tb00338.x","volume":"27","author":"L Anselin","year":"1995","unstructured":"Anselin L. Local indicators of spatial association - LISA. Geogr Anal. 1995;27(2):93\u2013115.","journal-title":"Geogr Anal"},{"issue":"3","key":"2296_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2307\/1912791","volume":"37","author":"CWJ Granger","year":"1969","unstructured":"Granger CWJ. Investigating Causal Relations by Econometric Models and Cross-spectral Methods. Econometrica. 1969;37(3):424\u201338.","journal-title":"Econometrica"},{"issue":"1","key":"2296_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/aos\/1176344552","volume":"7","author":"B Efron","year":"1979","unstructured":"Efron B. Bootstrap Methods: Another Look at the Jackknife. Annals Stat. 1979;7(1):1\u201326.","journal-title":"Annals Stat"},{"issue":"3 Suppl 1","key":"2296_CR21","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: a potentially modifiable relationship. Am J Prev Med. 2014;46(3 Suppl 1):S7\u201315.","journal-title":"Am J Prev Med"},{"issue":"3","key":"2296_CR22","first-page":"209","volume":"71","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2296_CR23","first-page":"270","volume":"19","author":"A Miranda-Filho","year":"2017","unstructured":"Miranda-Filho A, Pi\u00f1eros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol. 2017;19(2):270\u201380.","journal-title":"Neuro Oncol"},{"key":"2296_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1742-2094-9-155","volume":"9","author":"L Tian","year":"2012","unstructured":"Tian L, Ma L, Kaarela T, Li Z. Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J Neuroinflammation. 2012;9:155.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"2296_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/jleuko\/qiae230","volume":"116","author":"K Song","year":"2024","unstructured":"Song K, Kim BS. The peripheral neuroimmune system. J Leukoc Biol. 2024;116(6):1291\u2013300.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2296_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11060-017-2676-5","volume":"136","author":"E Goethe","year":"2018","unstructured":"Goethe E, Carter BZ, Rao G, Pemmaraju N. Glioblastoma and acute myeloid leukemia: malignancies with striking similarities. J Neurooncol. 2018;136(2):223\u201331.","journal-title":"J Neurooncol"},{"key":"2296_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/JBM.S70716","volume":"7","author":"J Mondesir","year":"2016","unstructured":"Mondesir J, Willekens C, Touat M, de Botton S. IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives. J Blood Med. 2016;7:171\u201380.","journal-title":"J Blood Med"},{"issue":"20","key":"2296_CR31","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","volume":"18","author":"H Yang","year":"2012","unstructured":"Yang H, Ye D, Guan KL, Xiong Y. IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clin Cancer Res. 2012;18(20):5562\u201371.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2296_CR32","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3324\/haematol.2010.030015","volume":"95","author":"M Cazzola","year":"2010","unstructured":"Cazzola M. IDH1 and IDH2 mutations in myeloid neoplasms\u2013novel paradigms and clinical implications. Haematologica. 2010;95(10):1623\u20137.","journal-title":"Haematologica"},{"issue":"2","key":"2296_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017;377(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"14","key":"2296_CR34","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","volume":"119","author":"HC Hasselbalch","year":"2012","unstructured":"Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood. 2012;119(14):3219\u201325.","journal-title":"Blood"},{"key":"2296_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fncel.2014.00418","volume":"8","author":"LG Dubois","year":"2014","unstructured":"Dubois LG, Campanati L, Righy C, D\u2019Andrea-Meira I, Spohr TC, Porto-Carreiro I, et al. Gliomas and the vascular fragility of the blood brain barrier. Front Cell Neurosci. 2014;8:418.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2296_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci. 2016;19(1):20\u20137.","journal-title":"Nat Neurosci"},{"issue":"1","key":"2296_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1124\/jpet.120.265058","volume":"375","author":"A Gopinath","year":"2020","unstructured":"Gopinath A, Collins A, Khoshbouei H, Streit WJ. Microglia and other myeloid cells in central nervous system health and disease. J Pharmacol Exp Ther. 2020;375(1):154\u201360.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"2296_CR38","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.immuni.2017.06.007","volume":"46","author":"J Herz","year":"2017","unstructured":"Herz J, Filiano AJ, Wiltbank AT, Yogev N, Kipnis J. Myeloid Cells in the Central Nervous System. Immunity. 2017;46(6):943\u201356.","journal-title":"Immunity"},{"key":"2296_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213364","author":"J Mills","year":"2022","unstructured":"Mills J, Ladner L, Soliman E, Leonard J, Morton PD, Theus MH. Cross-talk and subset control of microglia and associated myeloid cells in neurological disorders. Cells. 2022. . https:\/\/doi.org\/10.3390\/cells11213364","journal-title":"Cells"},{"issue":"3","key":"2296_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell. 2017;31(3):326\u201341.","journal-title":"Cancer Cell"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02296-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:17:17Z","timestamp":1790997437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02296-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02296-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Original primary study investigators previously secured all necessary institutional ethical approvals and baseline informed patient consent. This current study conducts secondary analyses utilizing completely anonymized public summary statistics. Formal institutional review board exemption therefore applies.","order":3,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"346"}}